Joshua Reed - Feb 7, 2024 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
Chief Financial Officer
Signature
/s/ Barbara Chan as Attorney-in-Fact for Joshua Reed
Stock symbol
OMGA
Transactions as of
Feb 7, 2024
Transactions value $
$0
Form type
4
Date filed
2/9/2024, 04:57 PM
Previous filing
Jun 22, 2023
Next filing
Jul 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Stock Option (Right to Buy) Award $0 +110K $0.00 110K Feb 7, 2024 Common Stock 110K $3.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable with respect to 25% of the underlying shares on February 7, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on February 7, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.